ENG/中
老虎证券
行情
产品介绍
Cash Boost账户
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息（分红）
专栏
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登录
立即注册
Toggle
美股
详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务
Therapix Biosciences Ltd.
0.3170
0.0000
成交量：
- -
成交额：
- -
市值：
181.31万
市盈率：
-0.11
高：
0.3170
开：
0.3170
低：
0.3170
收：
0.3170
数据加载中...
总览
公司
新闻
公告
2019/11/19
非美公司披露报告
Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/13
非美公司披露报告
Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/07
非美公司披露报告
Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/15
非美公司披露报告
Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/11
非美公司披露报告
Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/03
SEC问询函
[Cover]Correspondence
2019/08/29
SEC问询函
[Cover]Correspondence
2019/08/27
非美公司披露报告
Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/31
非美公司披露报告
Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/23
非美公司披露报告
Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/05
非美公司披露报告
Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/18
非美公司披露报告
Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/29
非美公司披露报告
Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/23
非美公司披露报告
Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/15
年度报告
Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2019/03/28
非美公司披露报告
Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/26
非美公司披露报告
Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/19
非美公司披露报告
Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/13
非美公司披露报告
Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/07
非美公司披露报告
Report of foreign issuer [Rules 13a-16 and 15d-16]
更多
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/TRPX/filings?page=3"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TRPX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TRPX\",,,,,undefined,":{"symbol":"TRPX","market":"US","secType":"STK","nameCN":"Therapix Biosciences Ltd.","latestPrice":0.317,"timestamp":1593633600000,"preClose":0.317,"halted":4,"volume":0,"delay":0,"floatShares":5578438,"shares":5719700,"eps":-2.797749,"marketStatus":"退市","change":0,"latestTime":"05-22 10:44:11 EDT","open":0.317,"high":0.317,"low":0.317,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-2.797749,"tradingStatus":0,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1747944000000},"marketStatusCode":2,"adr":0,"adrRate":40,"listingDate":1490155200000,"exchange":"NASDAQ","adjPreClose":0.317,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TRPX\",,,,,undefined,":{"symbol":"TRPX","floatShares":5578438,"roa":"-89.87%","roe":"-9843.96%","lyrEps":-170.15344,"shares":5719700,"dividePrice":0,"high":0.317,"amplitude":0,"preClose":0.317,"low":0.317,"week52Low":0.2522,"pbRate":"129.51","week52High":4.69,"institutionHeld":0,"latestPrice":0.317,"eps":-2.797749,"divideRate":0,"volume":0,"delay":0,"ttmEps":-2.797749,"open":0.317},"$inf$@#url:\"https://stock-news.skytigris.cn/v3/notice/important/events/list\",params:#symbol:\"TRPX\",pageSize:20,pageCount:3,market:\"us\",,,undefined,":[{"items":[{"cdn_pdf":false,"hasAttachments":true,"id":"8854076","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390019023975-TRPX","pdf_url":null,"pub_time":1574092800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Report of foreign issuer [Rules 13a-16 and 15d-16]","symbol":"TRPX","title":"Report of foreign issuer [Rules 13a-16 and 15d-16]","titleType":"非美公司披露报告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019023975/0001213900-19-023975-index.htm","us_notice_code":"Form 6-K","us_title_en":"Report of foreign issuer [Rules 13a-16 and 15d-16]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"PRESS RELEASE ISSUED BY THERAPIX BIOSCIENCES LTD. ON NOVEMBER 18, 2019, TITLED \"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019023975/f6k111919ex99-1_therapixbio.htm","primary":true,"translateUrl":null,"linkName":"f6k111919ex99-1_therapixbio.htm","type":"EX-99.1","id":"NTFILEH9YGaJfHzvJ5CFPy","market":"us","size":16264},{"description":"REPORT OF FOREIGN PRIVATE ISSUER","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019023975/f6k111919_therapixbio.htm","primary":false,"translateUrl":null,"linkName":"f6k111919_therapixbio.htm","type":"6-K","id":"NTFILEDKg5aohSuQ8iHZHV","market":"us","size":16655},{"description":"GRAPHIC","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019023975/ex99-1_001.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_001.jpg","type":"GRAPHIC","id":"NTFILE7f6a6994Yh8RgwYG","market":"us","size":29733}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Report of foreign issuer","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"非美公司披露报告","pubTime":"2019-11-19 00:00","pubTimestamp":1574092800,"title_zh":"Report of foreign issuer [Rules 13a-16 and 15d-16","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"8854088","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390019023174-TRPX","pdf_url":null,"pub_time":1573574400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Report of foreign issuer [Rules 13a-16 and 15d-16]","symbol":"TRPX","title":"Report of foreign issuer [Rules 13a-16 and 15d-16]","titleType":"非美公司披露报告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019023174/0001213900-19-023174-index.htm","us_notice_code":"Form 6-K","us_title_en":"Report of foreign issuer [Rules 13a-16 and 15d-16]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"PRESS RELEASE ISSUED BY THERAPIX BIOSCIENCES LTD. ON NOVEMBER 13, 2019, TITLED \"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019023174/f6k111319ex99-1_therapix.htm","primary":true,"translateUrl":null,"linkName":"f6k111319ex99-1_therapix.htm","type":"EX-99.1","id":"NTFILECLoyAMJHxLKmhiMq","market":"us","size":9358},{"description":"REPORT OF FOREIGN PRIVATE ISSUER","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019023174/f6k111319_therapixbiosci.htm","primary":false,"translateUrl":null,"linkName":"f6k111319_therapixbiosci.htm","type":"6-K","id":"NTFILE4ez3KB31FQVMQijh","market":"us","size":12003},{"description":"GRAPHIC","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019023174/ex99-1_001.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_001.jpg","type":"GRAPHIC","id":"NTFILEGoshZfhQ5MhZGt4J","market":"us","size":28109}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Report of foreign issuer","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"非美公司披露报告","pubTime":"2019-11-13 00:00","pubTimestamp":1573574400,"title_zh":"Report of foreign issuer [Rules 13a-16 and 15d-16","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"8854057","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390019022402-TRPX","pdf_url":null,"pub_time":1573056000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Report of foreign issuer [Rules 13a-16 and 15d-16]","symbol":"TRPX","title":"Report of foreign issuer [Rules 13a-16 and 15d-16]","titleType":"非美公司披露报告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019022402/0001213900-19-022402-index.htm","us_notice_code":"Form 6-K","us_title_en":"Report of foreign issuer [Rules 13a-16 and 15d-16]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"PRESS RELEASE ISSUED BY THERAPIX BIOSCIENCES LTD. ON NOVEMBER 7, 2019, TITLED ?T","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019022402/f6k110619ex99-1_therapixbio.htm","primary":true,"translateUrl":null,"linkName":"f6k110619ex99-1_therapixbio.htm","type":"EX-99.1","id":"NTFILEBBftxg4RDXRjfRMG","market":"us","size":8592},{"description":"REPORT OF FOREIGN PRIVATE ISSUER","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019022402/f6k110619_therapixbioscience.htm","primary":false,"translateUrl":null,"linkName":"f6k110619_therapixbioscience.htm","type":"6-K","id":"NTFILEAwiQeCT4ZyJi5cFc","market":"us","size":14797},{"description":"THERAPIX BIOSCIENCES LTD.'S UNAUDITED CONSOLIDATED INTERIM FINANCIAL STATEMENTS","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019022402/f6k110619ex99-2_therapixbio.htm","primary":false,"translateUrl":null,"linkName":"f6k110619ex99-2_therapixbio.htm","type":"EX-99.2","id":"NTFILELRubWCEiGT3Av2TA","market":"us","size":384511},{"description":"THERAPIX BIOSCIENCES LTD.'S MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CO","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019022402/f6k110619ex99-3_therapixbio.htm","primary":false,"translateUrl":null,"linkName":"f6k110619ex99-3_therapixbio.htm","type":"EX-99.3","id":"NTFILEH7ZcuTZSdXWfmYph","market":"us","size":57265},{"description":"XBRL INSTANCE FILE","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019022402/trpx-20190630.xml","primary":false,"translateUrl":null,"linkName":"trpx-20190630.xml","type":"EX-101.INS","id":"NTFILE8xrxwvg1HpjoYWbt","market":"us","size":432136},{"description":"XBRL SCHEMA FILE","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019022402/trpx-20190630.xsd","primary":false,"translateUrl":null,"linkName":"trpx-20190630.xsd","type":"EX-101.SCH","id":"NTFILE4PLDUCJjFEna1KLj","market":"us","size":52545},{"description":"XBRL CALCULATION FILE","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019022402/trpx-20190630_cal.xml","primary":false,"translateUrl":null,"linkName":"trpx-20190630_cal.xml","type":"EX-101.CAL","id":"NTFILE9id6rg6hZYNZtZPn","market":"us","size":49755},{"description":"XBRL DEFINITION FILE","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019022402/trpx-20190630_def.xml","primary":false,"translateUrl":null,"linkName":"trpx-20190630_def.xml","type":"EX-101.DEF","id":"NTFILE8qCBEeELjJuRkb8K","market":"us","size":96124},{"description":"XBRL LABEL FILE","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019022402/trpx-20190630_lab.xml","primary":false,"translateUrl":null,"linkName":"trpx-20190630_lab.xml","type":"EX-101.LAB","id":"NTFILE9hWWfCDRLE8gZyPh","market":"us","size":268256},{"description":"XBRL PRESENTATION FILE","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019022402/trpx-20190630_pre.xml","primary":false,"translateUrl":null,"linkName":"trpx-20190630_pre.xml","type":"EX-101.PRE","id":"NTFILEBrBCbFKWZouKbDfK","market":"us","size":185181}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Report of foreign issuer","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"非美公司披露报告","pubTime":"2019-11-07 00:00","pubTimestamp":1573056000,"title_zh":"Report of foreign issuer [Rules 13a-16 and 15d-16","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"8854083","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390019020353-TRPX","pdf_url":null,"pub_time":1571068800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Report of foreign issuer [Rules 13a-16 and 15d-16]","symbol":"TRPX","title":"Report of foreign issuer [Rules 13a-16 and 15d-16]","titleType":"非美公司披露报告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019020353/0001213900-19-020353-index.htm","us_notice_code":"Form 6-K","us_title_en":"Report of foreign issuer [Rules 13a-16 and 15d-16]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"PRESS RELEASE ISSUED BY THERAPIX BIOSCIENCES LTD. ON OCTOBER 15, 2019, TITLED \"T","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019020353/f6k101419ex99-1_therapix.htm","primary":true,"translateUrl":null,"linkName":"f6k101419ex99-1_therapix.htm","type":"EX-99.1","id":"NTFILEEoC4Pm5286a1GASf","market":"us","size":7834},{"description":"FORM 6-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019020353/f6k101419_therapixbio.htm","primary":false,"translateUrl":null,"linkName":"f6k101419_therapixbio.htm","type":"6-K","id":"NTFILEEeRrwWqnsfSsWMN3","market":"us","size":10957},{"description":"GRAPHIC","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019020353/ex99-1_001.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_001.jpg","type":"GRAPHIC","id":"NTFILE7Pwgf33P5hteWLHZ","market":"us","size":28995}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Report of foreign issuer","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"非美公司披露报告","pubTime":"2019-10-15 00:00","pubTimestamp":1571068800,"title_zh":"Report of foreign issuer [Rules 13a-16 and 15d-16","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"8854069","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390019020155-TRPX","pdf_url":null,"pub_time":1570723200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Report of foreign issuer [Rules 13a-16 and 15d-16]","symbol":"TRPX","title":"Report of foreign issuer [Rules 13a-16 and 15d-16]","titleType":"非美公司披露报告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019020155/0001213900-19-020155-index.htm","us_notice_code":"Form 6-K","us_title_en":"Report of foreign issuer [Rules 13a-16 and 15d-16]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"PRESS RELEASE ISSUED BY THERAPIX BIOSCIENCES LTD. ON OCTOBER 10, 2019, TITLED \"T","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019020155/f6k101019ex99-1_therapixbio.htm","primary":true,"translateUrl":null,"linkName":"f6k101019ex99-1_therapixbio.htm","type":"EX-99.1","id":"NTFILEDSHJyaBBkq8dkyi6","market":"us","size":5981},{"description":"CURRENT REPORT OF FOREIGN ISSUER","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019020155/f6k101019_therapixbio.htm","primary":false,"translateUrl":null,"linkName":"f6k101019_therapixbio.htm","type":"6-K","id":"NTFILEXr42BPtfxZbTa5pj","market":"us","size":10410},{"description":"GRAPHIC","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019020155/image_001.jpg","primary":false,"translateUrl":null,"linkName":"image_001.jpg","type":"GRAPHIC","id":"NTFILE2ndKNrRU8Drr7Uhj","market":"us","size":11678}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Report of foreign issuer","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"非美公司披露报告","pubTime":"2019-10-11 00:00","pubTimestamp":1570723200,"title_zh":"Report of foreign issuer [Rules 13a-16 and 15d-16","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"8854071","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390019017107-TRPX","pdf_url":null,"pub_time":1567440000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"[Cover]Correspondence","symbol":"TRPX","title":"[Cover]Correspondence","titleType":"SEC问询函","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019017107/0001213900-19-017107-index.htm","us_notice_code":"Form CORRESP","us_title_en":"[Cover]Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019017107/filename1.htm","primary":true,"translateUrl":null,"linkName":"filename1.htm","type":"CORRESP","id":"NTFILE59hZUT53fpoaJWny","market":"us","size":6496}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"SEC问询函","pubTime":"2019-09-03 00:00","pubTimestamp":1567440000,"title_zh":"Cover]Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"8854036","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390019016954-TRPX","pdf_url":null,"pub_time":1567008000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"[Cover]Correspondence","symbol":"TRPX","title":"[Cover]Correspondence","titleType":"SEC问询函","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019016954/0001213900-19-016954-index.htm","us_notice_code":"Form CORRESP","us_title_en":"[Cover]Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019016954/filename1.htm","primary":true,"translateUrl":null,"linkName":"filename1.htm","type":"CORRESP","id":"NTFILEHJfmb5rb7Z7wJsh3","market":"us","size":10625}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"SEC问询函","pubTime":"2019-08-29 00:00","pubTimestamp":1567008000,"title_zh":"Cover]Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"8854039","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390019016788-TRPX","pdf_url":null,"pub_time":1566835200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Report of foreign issuer [Rules 13a-16 and 15d-16]","symbol":"TRPX","title":"Report of foreign issuer [Rules 13a-16 and 15d-16]","titleType":"非美公司披露报告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019016788/0001213900-19-016788-index.htm","us_notice_code":"Form 6-K","us_title_en":"Report of foreign issuer [Rules 13a-16 and 15d-16]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"PRESS RELEASE ISSUED BY THERAPIX BIOSCIENCES LTD. ON JULY 31, 2019, TITLED NASDA","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019016788/f6k082719ex99-1_therapixbio.htm","primary":true,"translateUrl":null,"linkName":"f6k082719ex99-1_therapixbio.htm","type":"EX-99.1","id":"NTFILEHTK7CatRSfiK9dMc","market":"us","size":8547},{"description":"FORM 6-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019016788/f6k082719_therapixbio.htm","primary":false,"translateUrl":null,"linkName":"f6k082719_therapixbio.htm","type":"6-K","id":"NTFILE8abK43vqGNCx5DGU","market":"us","size":11806},{"description":"GRAPHIC","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019016788/image_001.jpg","primary":false,"translateUrl":null,"linkName":"image_001.jpg","type":"GRAPHIC","id":"NTFILE9F7SA4z648Y2qJza","market":"us","size":11678}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Report of foreign issuer","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"非美公司披露报告","pubTime":"2019-08-27 00:00","pubTimestamp":1566835200,"title_zh":"Report of foreign issuer [Rules 13a-16 and 15d-16","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"8438239","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390019014153-TRPX","pdf_url":null,"pub_time":1564502400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Report of foreign issuer [Rules 13a-16 and 15d-16]","symbol":"TRPX","title":"Report of foreign issuer [Rules 13a-16 and 15d-16]","titleType":"非美公司披露报告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019014153/0001213900-19-014153-index.htm","us_notice_code":"Form 6-K","us_title_en":"Report of foreign issuer [Rules 13a-16 and 15d-16]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"CURRENT REPORT OF FOREIGN ISSUER","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019014153/f6k073119_therapixbio.htm","primary":true,"translateUrl":null,"linkName":"f6k073119_therapixbio.htm","type":"6-K","id":"NTFILE7ph88S8CF2MMm1Ki","market":"us","size":11094},{"description":"RESS RELEASE ISSUED BY THERAPIX BIOSCIENCES LTD. ON JULY 31, 2019","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019014153/f6k073119ex99-1_therapixbio.htm","primary":false,"translateUrl":null,"linkName":"f6k073119ex99-1_therapixbio.htm","type":"EX-99.1","id":"NTFILE6k5mnGh2csbZG6ED","market":"us","size":10696},{"description":"GRAPHIC","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019014153/image_001.jpg","primary":false,"translateUrl":null,"linkName":"image_001.jpg","type":"GRAPHIC","id":"NTFILEGpx5raJVMcB6FAHc","market":"us","size":25370}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Report of foreign issuer","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"非美公司披露报告","pubTime":"2019-07-31 00:00","pubTimestamp":1564502400,"title_zh":"Report of foreign issuer [Rules 13a-16 and 15d-16","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"8416865","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390019013385-TRPX","pdf_url":null,"pub_time":1563811200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Report of foreign issuer [Rules 13a-16 and 15d-16]","symbol":"TRPX","title":"Report of foreign issuer [Rules 13a-16 and 15d-16]","titleType":"非美公司披露报告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019013385/0001213900-19-013385-index.htm","us_notice_code":"Form 6-K","us_title_en":"Report of foreign issuer [Rules 13a-16 and 15d-16]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"REPORT OF FOREIGN PRIVATE ISSUER","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019013385/f6k072319_therapixbio.htm","primary":true,"translateUrl":null,"linkName":"f6k072319_therapixbio.htm","type":"6-K","id":"NTFILE57Ex2s9dgwmRyQm9","market":"us","size":16989},{"description":"PRESS RELEASE ISSUED BY THERAPIX BIOSCIENCES LTD. ON JULY 23, 2019, TITLED \"THER","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019013385/f6k072319ex99-1_therapixbio.htm","primary":false,"translateUrl":null,"linkName":"f6k072319ex99-1_therapixbio.htm","type":"EX-99.1","id":"NTFILEk1oDMEaZ7rEyJL3D","market":"us","size":11635},{"description":"GRAPHIC","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019013385/ex99-1_001.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_001.jpg","type":"GRAPHIC","id":"NTFILE6dzKYRcctG52FWe6","market":"us","size":28446}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Report of foreign issuer","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"非美公司披露报告","pubTime":"2019-07-23 00:00","pubTimestamp":1563811200,"title_zh":"Report of foreign issuer [Rules 13a-16 and 15d-16","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"8370263","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390019012109-TRPX","pdf_url":null,"pub_time":1562256000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Report of foreign issuer [Rules 13a-16 and 15d-16]","symbol":"TRPX","title":"Report of foreign issuer [Rules 13a-16 and 15d-16]","titleType":"非美公司披露报告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019012109/0001213900-19-012109-index.htm","us_notice_code":"Form 6-K","us_title_en":"Report of foreign issuer [Rules 13a-16 and 15d-16]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"REPORT OF FOREIGN PRIVATE ISSUER","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019012109/f6k070519_therapixbio.htm","primary":true,"translateUrl":null,"linkName":"f6k070519_therapixbio.htm","type":"6-K","id":"NTFILE6vsBeSyVLe25oDuT","market":"us","size":10841},{"description":"PRESS RELEASE ISSUED BY THERAPIX BIOSCIENCES LTD. ON JULY 5, 2019, TITLED \"THERA","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019012109/f6k070519ex99-1_therapix.htm","primary":false,"translateUrl":null,"linkName":"f6k070519ex99-1_therapix.htm","type":"EX-99.1","id":"NTFILE2oXSgXP6pjLdtAVV","market":"us","size":20732},{"description":"GRAPHIC","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019012109/img_001.jpg","primary":false,"translateUrl":null,"linkName":"img_001.jpg","type":"GRAPHIC","id":"NTFILE45JXW523sefAtAZA","market":"us","size":7985}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Report of foreign issuer","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"非美公司披露报告","pubTime":"2019-07-05 00:00","pubTimestamp":1562256000,"title_zh":"Report of foreign issuer [Rules 13a-16 and 15d-16","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"8307939","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390019010947-TRPX","pdf_url":null,"pub_time":1560787200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Report of foreign issuer [Rules 13a-16 and 15d-16]","symbol":"TRPX","title":"Report of foreign issuer [Rules 13a-16 and 15d-16]","titleType":"非美公司披露报告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019010947/0001213900-19-010947-index.htm","us_notice_code":"Form 6-K","us_title_en":"Report of foreign issuer [Rules 13a-16 and 15d-16]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"REPORT OF FOREIGN PRIVATE ISSUER","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019010947/f6k061819_therapixbio.htm","primary":true,"translateUrl":null,"linkName":"f6k061819_therapixbio.htm","type":"6-K","id":"NTFILE5mpTNGYUxCLFSwMj","market":"us","size":11238},{"description":"PRESS RELEASE ISSUED BY THERAPIX BIOSCIENCES LTD. ON JUNE 18, 2019,","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019010947/f6k061819ex99-1_therapixbio.htm","primary":false,"translateUrl":null,"linkName":"f6k061819ex99-1_therapixbio.htm","type":"EX-99.1","id":"NTFILEAGwQAFEe8y3NrnQh","market":"us","size":8622},{"description":"GRAPHIC","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019010947/image_001.jpg","primary":false,"translateUrl":null,"linkName":"image_001.jpg","type":"GRAPHIC","id":"NTFILE4DzJeBR6D4QFAqbn","market":"us","size":8561}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Report of foreign issuer","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"非美公司披露报告","pubTime":"2019-06-18 00:00","pubTimestamp":1560787200,"title_zh":"Report of foreign issuer [Rules 13a-16 and 15d-16","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"8244047","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390019009717-TRPX","pdf_url":null,"pub_time":1559059200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Report of foreign issuer [Rules 13a-16 and 15d-16]","symbol":"TRPX","title":"Report of foreign issuer [Rules 13a-16 and 15d-16]","titleType":"非美公司披露报告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019009717/0001213900-19-009717-index.htm","us_notice_code":"Form 6-K","us_title_en":"Report of foreign issuer [Rules 13a-16 and 15d-16]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"REPORT OF FOREIGN PRIVATE ISSUER","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019009717/f6k052919_therapixbio.htm","primary":true,"translateUrl":null,"linkName":"f6k052919_therapixbio.htm","type":"6-K","id":"NTFILEA3DeUp1XAnsxJRje","market":"us","size":15937},{"description":"PRESS RELEASE ISSUED BY THERAPIX BIOSCIENCES LTD. ON MAY 29, 2019, TITLED \"THERA","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019009717/f6k052919ex99-1_therapix.htm","primary":false,"translateUrl":null,"linkName":"f6k052919ex99-1_therapix.htm","type":"EX-99.1","id":"NTFILEF2VT53tghw2wQ4xQ","market":"us","size":15478},{"description":"GRAPHIC","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019009717/ex99-1_001.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_001.jpg","type":"GRAPHIC","id":"NTFILEAEMEuXUnRgZu93aw","market":"us","size":27940}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Report of foreign issuer","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"非美公司披露报告","pubTime":"2019-05-29 00:00","pubTimestamp":1559059200,"title_zh":"Report of foreign issuer [Rules 13a-16 and 15d-16","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"8227195","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390019009513-TRPX","pdf_url":null,"pub_time":1558540800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Report of foreign issuer [Rules 13a-16 and 15d-16]","symbol":"TRPX","title":"Report of foreign issuer [Rules 13a-16 and 15d-16]","titleType":"非美公司披露报告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019009513/0001213900-19-009513-index.htm","us_notice_code":"Form 6-K","us_title_en":"Annual and transition report of foreign private issuers [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"CURRENT REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019009513/f6k052319_therapixbio.htm","primary":true,"translateUrl":null,"linkName":"f6k052319_therapixbio.htm","type":"6-K","id":"NTFILE3ovmeFNEJByErmdV","market":"us","size":10117},{"description":"PRESS RELEASE ISSUED BY THERAPIX BIOSCIENCES LTD. ON MAY 23, 2019, TITLED \"THERA","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019009513/f6k052319ex99-1_therapixbio.htm","primary":false,"translateUrl":null,"linkName":"f6k052319ex99-1_therapixbio.htm","type":"EX-99.1","id":"NTFILEC9KyGKWU8XHcBuh3","market":"us","size":5661},{"description":"GRAPHIC","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019009513/image_002.jpg","primary":false,"translateUrl":null,"linkName":"image_002.jpg","type":"GRAPHIC","id":"NTFILE21KELgc5onLgTb14","market":"us","size":27493}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Report of foreign issuer","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"非美公司披露报告","pubTime":"2019-05-23 00:00","pubTimestamp":1558540800,"title_zh":"Report of foreign issuer [Rules 13a-16 and 15d-16","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"8194563","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390019008868-TRPX","pdf_url":null,"pub_time":1557849600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Annual and transition report of foreign private issuers [Sections 13 or 15(d)]","symbol":"TRPX","title":"Annual and transition report of foreign private issuers [Sections 13 or 15(d)]","titleType":"年度报告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019008868/0001213900-19-008868-index.htm","us_notice_code":"Form 20-F","us_title_en":"Report of foreign issuer [Rules 13a-16 and 15d-16]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"ANNUAL REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019008868/f20f2018_therapixbiosciences.htm","primary":true,"translateUrl":null,"linkName":"f20f2018_therapixbiosciences.htm","type":"20-F","id":"NTFILEEt5c7rUNXRiNtiHa","market":"us","size":2079979},{"description":"DESCRIPTION OF SECURITIES","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019008868/f20f2018ex2d_therapixbio.htm","primary":false,"translateUrl":null,"linkName":"f20f2018ex2d_therapixbio.htm","type":"EX-2.(D)","id":"NTFILE2K11hGSSzTgZmVaA","market":"us","size":80059},{"description":"LICENSE AGREEMENT","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019008868/f20f2018ex4-2_therapixbio.htm","primary":false,"translateUrl":null,"linkName":"f20f2018ex4-2_therapixbio.htm","type":"EX-4.2","id":"NTFILE7fgcEYwTKbTkGuzA","market":"us","size":403397},{"description":"CERTIFICATION","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019008868/f20f2018ex12-1_therapixbio.htm","primary":false,"translateUrl":null,"linkName":"f20f2018ex12-1_therapixbio.htm","type":"EX-12.1","id":"NTFILE3QZ5kn2Gt8gZrMyP","market":"us","size":7586},{"description":"CERTIFICATION","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019008868/f20f2018ex12-2_therapixbio.htm","primary":false,"translateUrl":null,"linkName":"f20f2018ex12-2_therapixbio.htm","type":"EX-12.2","id":"NTFILECDQ3jEHAGhk4ohp4","market":"us","size":7449},{"description":"CERTIFICATION","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019008868/f20f2018ex13-1_therapixbio.htm","primary":false,"translateUrl":null,"linkName":"f20f2018ex13-1_therapixbio.htm","type":"EX-13.1","id":"NTFILE4VbTJW9nBDU7AP1B","market":"us","size":3143},{"description":"CERTIFICATION","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019008868/f20f2018ex13-2_therapixbio.htm","primary":false,"translateUrl":null,"linkName":"f20f2018ex13-2_therapixbio.htm","type":"EX-13.2","id":"NTFILEBJyw2AdupK8J3ou7","market":"us","size":2931},{"description":"CONSENT","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019008868/f20f2018ex15-1_therapixbio.htm","primary":false,"translateUrl":null,"linkName":"f20f2018ex15-1_therapixbio.htm","type":"EX-15.1","id":"NTFILE7JD5rC9ANxbCuR88","market":"us","size":3842},{"description":"GRAPHIC","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019008868/img_001.jpg","primary":false,"translateUrl":null,"linkName":"img_001.jpg","type":"GRAPHIC","id":"NTFILEDDC5naKkHS8Qf85S","market":"us","size":2317},{"description":"GRAPHIC","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019008868/ex15-1_001.jpg","primary":false,"translateUrl":null,"linkName":"ex15-1_001.jpg","type":"GRAPHIC","id":"NTFILE66xKT6jaNmQeDUqL","market":"us","size":2265}],"type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Annual Report","us_type":"usFinancials","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"年度报告","pubTime":"2019-05-15 00:00","pubTimestamp":1557849600,"title_zh":"Annual and transition report of foreign private issuers [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"7938908","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390019005045-TRPX","pdf_url":null,"pub_time":1553702400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Report of foreign issuer [Rules 13a-16 and 15d-16]","symbol":"TRPX","title":"Report of foreign issuer [Rules 13a-16 and 15d-16]","titleType":"非美公司披露报告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019005045/0001213900-19-005045-index.htm","us_notice_code":"Form 6-K","us_title_en":"Report of foreign issuer [Rules 13a-16 and 15d-16]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"REPORT OF FOREIGN PRIVATE ISSUER","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019005045/f6k032819_therapixbio.htm","primary":true,"translateUrl":null,"linkName":"f6k032819_therapixbio.htm","type":"6-K","id":"NTFILE9RmpHMjy9PeniH3W","market":"us","size":18790},{"description":"FORM OF WARRANT BETWEEN THE COMPANY AND THE PURCHASERS IN THE OFFERINGS","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019005045/f6k032819ex4-1_therapix.htm","primary":false,"translateUrl":null,"linkName":"f6k032819ex4-1_therapix.htm","type":"EX-4.1","id":"NTFILEDy2rkgqaeMgJpDpz","market":"us","size":91568},{"description":"","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019005045/ex5_1.htm","primary":false,"translateUrl":null,"linkName":"ex5_1.htm","type":"EX-5.1","id":"NTFILE6Yd1QHRTxw6vVE7U","market":"us","size":10615},{"description":"FORM OF SECURITIES PURCHASE AGREEMENT BETWEEN THE COMPANY AND THE PURCHASERS IN","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019005045/f6k032819ex10-1_therapix.htm","primary":false,"translateUrl":null,"linkName":"f6k032819ex10-1_therapix.htm","type":"EX-10.1","id":"NTFILE4kmFjeqmx7HFf6Lp","market":"us","size":221890},{"description":"PRESS RELEASE DATED MARCH 28, 2019","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019005045/f6k032819ex99-1_therapix.htm","primary":false,"translateUrl":null,"linkName":"f6k032819ex99-1_therapix.htm","type":"EX-99.1","id":"NTFILEFEF2zQU9TqbzfF1i","market":"us","size":12852},{"description":"GRAPHIC","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019005045/img_001.jpg","primary":false,"translateUrl":null,"linkName":"img_001.jpg","type":"GRAPHIC","id":"NTFILE7uypZG9MFDomzXga","market":"us","size":15951},{"description":"GRAPHIC","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019005045/image_001.jpg","primary":false,"translateUrl":null,"linkName":"image_001.jpg","type":"GRAPHIC","id":"NTFILE988zd6ijJZQyanSy","market":"us","size":11319}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Report of foreign issuer","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"非美公司披露报告","pubTime":"2019-03-28 00:00","pubTimestamp":1553702400,"title_zh":"Report of foreign issuer [Rules 13a-16 and 15d-16","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"7926416","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390019004857-TRPX","pdf_url":null,"pub_time":1553529600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Report of foreign issuer [Rules 13a-16 and 15d-16]","symbol":"TRPX","title":"Report of foreign issuer [Rules 13a-16 and 15d-16]","titleType":"非美公司披露报告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019004857/0001213900-19-004857-index.htm","us_notice_code":"Form 6-K","us_title_en":"Report of foreign issuer [Rules 13a-16 and 15d-16]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"REPORT OF FOREIGN PRIVATE ISSUER","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019004857/f6k032519_therapixbiosc.htm","primary":true,"translateUrl":null,"linkName":"f6k032519_therapixbiosc.htm","type":"6-K","id":"NTFILE5oqvYnRc4w66ucoq","market":"us","size":15095}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Report of foreign issuer","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"非美公司披露报告","pubTime":"2019-03-26 00:00","pubTimestamp":1553529600,"title_zh":"Report of foreign issuer [Rules 13a-16 and 15d-16","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"7894206","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390019004417-TRPX","pdf_url":null,"pub_time":1552924800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Report of foreign issuer [Rules 13a-16 and 15d-16]","symbol":"TRPX","title":"Report of foreign issuer [Rules 13a-16 and 15d-16]","titleType":"非美公司披露报告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019004417/0001213900-19-004417-index.htm","us_notice_code":"Form 6-K","us_title_en":"Report of foreign issuer [Rules 13a-16 and 15d-16]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"REPORT OF FOREIGN PRIVATE ISSUER","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019004417/f6k031919_therapixbiosci.htm","primary":true,"translateUrl":null,"linkName":"f6k031919_therapixbiosci.htm","type":"6-K","id":"NTFILE9yvn8yW2RX6daMsG","market":"us","size":16884},{"description":"PRESS RELEASE ISSUED BY THERAPIX BIOSCIENCES LTD. ON MARCH 19, 2019, ANNOUNCING","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019004417/f6k031919ex99-1_therapix.htm","primary":false,"translateUrl":null,"linkName":"f6k031919ex99-1_therapix.htm","type":"EX-99.1","id":"NTFILE4Fcpd4DsguiJoJic","market":"us","size":8875},{"description":"GRAPHIC","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019004417/ex99-1_001.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_001.jpg","type":"GRAPHIC","id":"NTFILECBDggQEtgS9Z7vw5","market":"us","size":21935}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Report of foreign issuer","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"非美公司披露报告","pubTime":"2019-03-19 00:00","pubTimestamp":1552924800,"title_zh":"Report of foreign issuer [Rules 13a-16 and 15d-16","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"7872470","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390019004041-TRPX","pdf_url":null,"pub_time":1552406400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Report of foreign issuer [Rules 13a-16 and 15d-16]","symbol":"TRPX","title":"Report of foreign issuer [Rules 13a-16 and 15d-16]","titleType":"非美公司披露报告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019004041/0001213900-19-004041-index.htm","us_notice_code":"Form 6-K","us_title_en":"Report of foreign issuer [Rules 13a-16 and 15d-16]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"REPORT OF FOREIGN PRIVATE ISSUER","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019004041/f6k031319_therapixbio.htm","primary":true,"translateUrl":null,"linkName":"f6k031319_therapixbio.htm","type":"6-K","id":"NTFILEDWBRVkCmwn3z8hKo","market":"us","size":16610}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Report of foreign issuer","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"非美公司披露报告","pubTime":"2019-03-13 00:00","pubTimestamp":1552406400,"title_zh":"Report of foreign issuer [Rules 13a-16 and 15d-16","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"7832870","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390019003758-TRPX","pdf_url":null,"pub_time":1551888000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Report of foreign issuer [Rules 13a-16 and 15d-16]","symbol":"TRPX","title":"Report of foreign issuer [Rules 13a-16 and 15d-16]","titleType":"非美公司披露报告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019003758/0001213900-19-003758-index.htm","us_notice_code":"Form 6-K","us_title_en":"Report of foreign issuer [Rules 13a-16 and 15d-16]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"REPORT OF FOREIGN PRIVATE ISSUER","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019003758/f6k030719_therapixiosciences.htm","primary":true,"translateUrl":null,"linkName":"f6k030719_therapixiosciences.htm","type":"6-K","id":"NTFILEGnNaHdxHCNeCsZdB","market":"us","size":11409}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Report of foreign issuer","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"非美公司披露报告","pubTime":"2019-03-07 00:00","pubTimestamp":1551888000,"title_zh":"Report of foreign issuer [Rules 13a-16 and 15d-16","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":3,"totalSize":124,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TRPX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2020-10-19","symbol":"TRPX","defaultRemindTime":1603114200000,"type":"split","dateTimestamp":1603080000000,"forFactor":10000000,"toFactor":142857,"ratio":70.00007},{"market":"US","date":"2019-05-15","symbol":"TRPX","fiscalQuarterEnding":"2018/12","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1557892800000,"reportTimeType":"","actualEps":-0.83},{"market":"US","date":"2018-12-03","symbol":"TRPX","fiscalQuarterEnding":"2018/09","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1543813200000,"reportTimeType":"","actualEps":-0.5},{"market":"US","date":"2018-08-20","symbol":"TRPX","fiscalQuarterEnding":"2018/06","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1534737600000,"reportTimeType":"","actualEps":-0.35},{"market":"US","date":"2018-05-31","symbol":"TRPX","fiscalQuarterEnding":"2018/03","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1527739200000,"reportTimeType":"","actualEps":0.59}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TRPX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TRPX\",market:\"US\",delay:false,,,undefined,":{}}}